Stock Analysis on Net

Synopsys Inc. (NASDAQ:SNPS)

Balance Sheet: Liabilities and Stockholders’ Equity

Synopsys Inc., consolidated balance sheet: liabilities and stockholders’ equity

US$ in thousands

Microsoft Excel
Oct 31, 2023 Oct 31, 2022 Oct 31, 2021 Oct 31, 2020 Oct 31, 2019 Oct 31, 2018
Payroll and related benefits 583,854 559,886 581,687 492,626 417,157 413,307
Accrued income taxes 226,762 35,290
Other accrued liabilities 157,254 176,647 132,091 128,773 85,391 107,431
Accounts payable 155,891 37,580 27,413 30,003 19,815 85,046
Accounts payable and accrued liabilities 1,123,761 809,403 741,191 651,402 522,363 605,784
Current operating lease liabilities 85,690 54,274 79,678 73,173
Deferred revenue 1,776,000 1,910,822 1,517,623 1,388,263 1,212,476 1,152,862
Short-term debt 74,992 27,084 17,614 343,769
Current liabilities 2,985,451 2,774,499 2,413,484 2,139,922 1,752,453 2,102,415
Long-term operating lease liabilities 584,035 581,273 487,003 462,411
Long-term deferred revenue 175,128 154,472 136,303 104,850 90,102 116,859
Long-term debt 18,078 20,824 25,094 100,823 120,093 125,535
Deferred compensation plan liabilities 300,731 279,096 343,820 269,737 249,822 212,165
Other 85,407 48,733 47,613 39,952 103,814 103,985
Other long-term liabilities 386,138 327,829 391,433 309,689 353,636 316,150
Long-term liabilities 1,163,379 1,084,398 1,039,833 977,773 563,831 558,544
Total liabilities 4,148,830 3,858,897 3,453,317 3,117,695 2,316,284 2,660,959
Redeemable non-controlling interest 31,043 38,664
Preferred stock, $0.01 par value; none outstanding
Common stock, $0.01 par value 1,521 1,524 1,531 1,528 1,503 1,493
Capital in excess of par value 1,276,152 1,487,126 1,576,363 1,653,166 1,635,455 1,644,830
Retained earnings 6,741,699 5,534,307 4,549,713 3,795,397 3,164,144 2,543,688
Treasury stock, at cost (1,675,650) (1,272,955) (782,866) (488,613) (625,642) (597,682)
Accumulated other comprehensive loss (196,414) (234,277) (49,604) (54,074) (92,447) (113,177)
Total Synopsys stockholders’ equity 6,147,308 5,515,725 5,295,137 4,907,404 4,083,013 3,479,152
Non-controlling interest 5,950 4,801 3,806 4,963 5,863 5,863
Total stockholders’ equity 6,153,258 5,520,526 5,298,943 4,912,367 4,088,876 3,485,015
Total liabilities, redeemable non-controlling interest and stockholders’ equity 10,333,131 9,418,087 8,752,260 8,030,062 6,405,160 6,145,974

Based on: 10-K (reporting date: 2023-10-31), 10-K (reporting date: 2022-10-31), 10-K (reporting date: 2021-10-31), 10-K (reporting date: 2020-10-31), 10-K (reporting date: 2019-10-31), 10-K (reporting date: 2018-10-31).

Balance sheet item Description The company
Current liabilities Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Synopsys Inc. current liabilities increased from 2021 to 2022 and from 2022 to 2023.
Long-term liabilities Amount of obligation due after one year or beyond the normal operating cycle, if longer. Synopsys Inc. long-term liabilities increased from 2021 to 2022 and from 2022 to 2023.
Total liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. Synopsys Inc. total liabilities increased from 2021 to 2022 and from 2022 to 2023.
Total Synopsys stockholders’ equity Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Synopsys Inc. total Synopsys stockholders’ equity increased from 2021 to 2022 and from 2022 to 2023.